Skip to main content

Month: February 2024

Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia

TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third parties for cultivation across Colombia and Latin America. The two companies have already begun rigorous selection, phenotyping, and agronomic trials of several Paradise varieties at Clever Leaves’ facility in order to register market-leading cultivars for production and commercialization. Colombian regulations require official agronomic...

Continue reading

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call

SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call. The Company will release its fourth quarter 2023 results on Tuesday, February 27th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, February 27th, 2024. The call can be accessed at (833) 816-1376, conference ID 10186026. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company’s website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will...

Continue reading

Latham Group, Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Earnings Release and Conference Call Date

LATHAM, N.Y., Feb. 13, 2024 (GLOBE NEWSWIRE) — Latham Group, Inc. (“Latham” or “the Company”), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that it will release financial results for the fourth quarter and fiscal year 2023 on Tuesday, March 12, 2024, after the close of the U.S. market. The Company will hold a conference call to discuss the results that same day at 4:30 p.m. Eastern Time. We encourage participants to pre-register for the conference call by visiting https://dpregister.com/sreg/10186506/fb9d52b71a. Callers who pre-register will be sent a confirmation e-mail including a conference passcode and unique PIN to gain immediate access to the call. Participants may pre-register at any time, including up to and after the...

Continue reading

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) — Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences® (Nasdaq: MRVI), announced today a strategic partnership for the quantification of Host Cell Proteins (“HCP”) from the proprietary and patented C1-cells filamentous fungus Thermothelomyces heterothallica, (formerly Myceliophthora thermophila). Under the terms of the partnership agreement, Cygnus has developed the C1 HCP ELISA Kit, which will be made available to Dyadic and Cygnus customers. HCP measurements are critical quality-control steps in biopharmaceutical development because the presence of these impurities in the final product can potentially interfere with drug efficacy, induce an undesired immune response, or impact drug stability....

Continue reading

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

Lantheus to supply MK-6240, an investigational F18-labeled PET imaging agent that targets tau tangles BEDFORD, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced a collaboration agreement with a National Institute on Aging (NIA)-sponsored study called the Consortium for Clarity in ADRD Research Through Imaging (CLARiTI). This agreement enables the consortium to use MK-6240, Lantheus’ clinical-stage F18-labeled Positron Emission Tomography (PET) imaging agent, in its investigation of Alzheimer’s disease and related dementias. MK-6240 targets aggregated tau protein in the form of neurofibrillary tangles (NFTs) which are a hallmark...

Continue reading

Blüm Holdings Executes Binding LOI to Acquire $14 Million Portfolio of Retail Assets Including Iconic Cookies Cannabis Dispensary

SANTA ANA, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — Blüm Holdings, Inc. (OTCQB: BLMH) (“Company,” “Blüm Holdings,” “we” or “us”), a cannabis company with operations throughout California, is pleased to announce the execution of a Binding Letter of Intent (“Binding LOI”) with Operators Only Corporation (“Operators Only”) to add three additional dispensaries to its retail portfolio (the “Proposed Acquisition”). If completed, the Proposed Acquisition could represent a significant milestone in Blüm Holdings’ expansion strategy and may help solidify the Company’s position as a key player in Northern California’s retail landscape. Operators Only owns and operates three retail stores in Sacramento, including a flagship Cookies cannabis dispensary located in downtown Sacramento, a dispensary in North Sacramento, and another in South Sacramento. “We...

Continue reading

LPL Financial to Acquire Atria Wealth Solutions

Atria Wealth Solutions supports approximately 2,400 advisors and 150 banks and credit unions, managing approximately $100 billion of brokerage and advisory assets SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (NASDAQ: LPLA) (together with its subsidiaries, including LPL Financial LLC, “LPL Financial” or “LPL”) today announced that the firm has entered into a definitive purchase agreement to acquire Atria Wealth Solutions, Inc., (“Atria”), a wealth management solutions holding company headquartered in New York. Atria supports approximately 2,400 advisors and 150 banks and credit unions, managing approximately $100 billion of brokerage and advisory assets. Established in 2017, Atria operates a network of broker-dealer subsidiaries focused on supporting independent financial advisors and institutions nationwide. “Atria...

Continue reading

NETSOL Technologies Reports 23% Revenue Growth and EPS of $0.04 in Fiscal Second Quarter 2024

Strong licensing fees and increased recurring revenues 2Q ‘24 Gross Margins of 47% up from 25% in 2Q’ 23 Company on track for strong double digit organic revenue growth and profitability in fiscal 2024ENCINO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, reported results for the fiscal second quarter of 2024 ended December 31, 2023. Fiscal Second Quarter 2024 Financial Results Total net revenues for the second quarter of fiscal 2024 increased 23% to $15.2 million, compared with $12.4 million in the prior year period. On a constant currency basis, total net revenues were $15.3 million.License fees were $3.0 million compared with $16,000 in the prior year period. License fees on a constant currency basis were $3.1 million. Total...

Continue reading

A/S Øresund : Information on the State aid case

Today A/S Øresund has received information that the EU Commission has reached a new decision on the matter on state aid concerning the Øresundsbro Consortium. In the coming weeks, A/S Øresund will together with the Ministry of Transport analyze the impact of the new state aid decision and follow-up. Link to EU commission press release.Public financing of Øresund (europa.eu) Please refer to the Ministry of Transport for further comments.AttachmentCommission_closes_State_aid_investigation_into_Danish_and_Swedish_public_financing_of__resund_fixed_rail-road_link

Continue reading

GCM Grosvenor Reports Fourth Quarter and Full Year 2023 Earnings Results

CHICAGO, Feb. 13, 2024 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG) today reported its results for the fourth quarter and full year 2023, which have been posted to the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events. A conference call to discuss GCM Grosvenor’s financial results will be held today, Tuesday, February 13, 2024, at 10:00 a.m. ET. The call will be accessible via public webcast from the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events, and a replay of the live broadcast will be available on the website soon after the call’s completion. The call can also be accessed by dialing (888) 224-1005 (toll-free) or (929) 477-0402 and using the passcode 8018339. About GCM Grosvenor GCM Grosvenor (Nasdaq: GCMG)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.